Navigation Links
Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
Date:11/7/2007

WALTHAM, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI), a genetics-focused personalized health company that develops preventive consumer products and genetic tests for sale to the emerging personalized health market, today announced results for its third quarter ended September 30, 2007.

The Company recorded revenue of $2.6 million for the third quarter, compared to revenue of $1.3 million for third quarter ended September 30, 2006, a 92% increase. Net loss for the quarter was $1.1 million, or $(0.04) per basic and diluted share compared to a net loss of $1.8 million, or $(0.07) per basic and diluted share for the same quarter last year.

The increase in revenue for the third quarter was attributable to the Company's Consumer Products segment which sells branded nutritional supplemental products to mass retail outlets. Interleukin reported $158,000 in revenue from its Genetic Testing segment, $1.8 million in revenue from its Consumer Products segment and $609,000 in revenue from its Research segment.

"During the quarter we refined our focus to better leverage our science and further establish Interleukin's leadership position in genetic testing and the personal wellness field", said Thomas Curran, interim Chief Executive Officer. "We have prioritized new product development programs in areas of significant opportunity such as gastric cancer and obesity. We continue to focus our efforts on our strategic relationship with Alticor to ensure strong marketing efforts and a positive consumer experience. As we look forward to the rollout of additional products in coming years we continue to explore new delivery channels and other potential strategic partners worldwide."


'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Interleukin Genetics Announces Management and Board Appointments
2. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 2014 Not long ago, it was ... be performed late in the development cycle – even ... regulatory trends suggest that, like many things GxP, expectations ... recent years, multiple drug sponsors have been required by ... questions during phase I/II. It’s not only clinical trial ...
(Date:8/19/2014)... NJ (PRWEB) August 20, 2014 ... and regenerative medicine is an inadequate vascular supply. ... constructs and decellularized tissues is critical for successful ... have attempted to mitigate deficiencies in vascularization and ... adding scaffold bioactivity, optimizing scaffold design and architecture, ...
(Date:8/19/2014)... 19, 2014 Research and Markets  has announced ... - Global Strategic Business Report" report to their offering. ... Solid Oxide Fuel Cells (SOFCs) in US$ Thousands. The report ... , Europe , Asia-Pacific ... are provided for the period 2012 through 2020. Market data ...
(Date:8/19/2014)... 2012, the European Union (EU) mandated use of the ICH-recommended ... – responding to the increasing need to understand and manage ... many regions, the main objectives of the PBRER are to:, ... of new or emerging information on the risks of a ... potential benefits of a drug; and , Allow ...
Breaking Biology Technology:Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2Vascularization in Tissue Engineering Highlighted at 12th New Jersey Symposium on Biomaterials Science 2Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014 2Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2
... , Integrated system simplifies and improves Northern blot ... , Streamline RNA analysis with a whole host of ... total RNA miniprep kit is,used to isolate ample ... RNA is ready to use in a number of ...
... Improve reliability of PCR reactions with Herculase ... Holly Hogrefe ,Stratagene , Stratagene recently released ... novel enzyme formulation that provides,superior performance in both ... Herculase DNA polymerase exhibits greater fidelity than,commercial DNA ...
... still video system to directly acquire,images from chemiluminescent ... ,Stratagene , The Eagle Eye II ... of chemiluminescent Western blots. The light-tight cabinet is ... chemiluminescent signals. Also,the systems charge-coupled device (CCD) camera ...
Cached Biology Technology:Tools for Detecting MSH2 Expression in Chinese Hamster Ovary Cells 2Tools for Detecting MSH2 Expression in Chinese Hamster Ovary Cells 3Tools for Detecting MSH2 Expression in Chinese Hamster Ovary Cells 4Tools for Detecting MSH2 Expression in Chinese Hamster Ovary Cells 5Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR,Performance 2Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR,Performance 3Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR,Performance 4Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR,Performance 5Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR,Performance 6Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR,Performance 7Unique Enhanced DNA Polymerase Delivers High Fidelity and Great PCR,Performance 8Imaging Chemiluminescent Western Blots 2Imaging Chemiluminescent Western Blots 3
(Date:8/20/2014)... In a study of 158 pregnant teenagers in Rochester, ... and intentional consumption of ice, cornstarch, vacuum dust, baby ... new Cornell study. , Moreover, such teens had significantly ... not eat nonfood substances. , Pregnant teens, regardless of ... can lead to iron deficiency and anemia. Low iron ...
(Date:8/20/2014)... Arizona State University, the Wellcome Trust Sanger Institute and ... isolated Mycobacterium pinnipedii from skeletons found in ... pathogen is a relative of the TB bacterium that ... today. These researchers assume that seals carried the pathogens ... sea lions was unexpected" comments Sebastien Gagneux, from the ...
(Date:8/20/2014)... the Oklahoma Medical Research Foundation a five-year, $14.5 million ... bacteria,s effects on humans. , For 10 years, ... studied the human immune response to anthrax bacteria as ... original funding came soon after anthrax-laced letters killed five ... attacks of Sept. 11, 2001. , The long-term ...
Breaking Biology News(10 mins):Pica in pregnant teens linked to low iron 2$14.5 million grant awarded to continue anthrax studies 2
... PROVIDENCE, RI An injury to the anterior cruciate ... While it can often be corrected through surgery, the ... joint diseases, including osteoarthritis (OA). The problem is that ... is impacted by the trauma of the injury and ...
... in the United States as a result of trauma and ... bone fusion but with limited mechanical strength often due to ... harvest without pain and severe morbidity. Funded by the National ... of Chemistry, Chemical Biology and Biomedical Engineering at Stevens Institute ...
... to whether we will likely succeed or fail at a ... levels of neural effort put forth in movement-planning circuits in ... neuroscientists at the California Institute of Technology (Caltech). ... James G. Boswell Professor of Neuroscience at Caltechappears in the ...
Cached Biology News:Lubricating the knee cartilage after ACL repair may prevent osteoarthritis 2Lubricating the knee cartilage after ACL repair may prevent osteoarthritis 3NSF funds innovative approach to biomimetic nanofiber bone regeneration 2NSF funds innovative approach to biomimetic nanofiber bone regeneration 3Caltech: Gain and loss in optimistic versus pessimistic brains 2Caltech: Gain and loss in optimistic versus pessimistic brains 3
... The ULS cDNA Synthesis and Labeling Kit ... hybridization experiments. First unmodified cDNA is made ... cDNA using an Oligo(dT) primer. Unlike other ... used in the reverse transcription reaction. This ...
... Dot Blot Kits overcome this limitation and ... a wide range in low-density protein array ... They are ideal for performing reverse-phase protein ... for the presence of low abundant antigens. ...
AC input: 50-60 Hz230 V...
... arraying proteins of interest with sensitive ... DiscoverLight Protein Array Kits allow for ... lysate or antibody in a low-density ... designed nitrocellulose membranes with a 384-grid ...
Biology Products: